Allergic Asthma is driven by Nerve and Immune cells
Allergic asthma is a chronic inflammatory condition in which your lungs become inflamed and the airways you breathe through tighten when you inhale any kind of allergen. It is the most common type of asthma. About 90% of kids with…
New Biomarker to Diagnose Vascular Dementia
Sometimes it can be challenging for doctors to detect whether the patient’s cognitive impairment originates from Alzheimer’s disease or vascular problems. These are the two major reasons to cause vascular dementia. Usually, doctors rely on MRI or CAT scans to…
An In-Vitro Fully Human Ovarian Organoid Supporting Egg Cell Maturation
We all start as egg cells in our mother’s ovaries. Scientists have been working on generating in vitro models for the ovaries so that we can study more about them since the female reproductive organs are surprisingly understudied till now….
Bond Villain DNA: The game changer for cancer treatment
A group of researchers have found the pieces of DNA that help cancer to spread hence called to be ‘Bond Villain’. This segment of genetic material known as Extrachromosomal DNA or ecDNA was found by scientists, working on a project…
Alzheimer’s Disease Hallmarks Decrease on Removal of Neuronal Lipoprotein in Mice.
Cholesterol is the main structural component of the brain and it is transported and distributed through the Central Nervous System (CNS) with the help of the lipid metabolic cycle. Alzheimer’s disease (AD) patients often suffer through ‘Multimorbidity’ (meaning: multiple chronic…
Xylazine Drug Turning Humans into Zombies in US
A new drug named Xylazine or Tranq has caused a major havoc in different cities across US by severe symptoms like skin rotting a.k.a zombie like effect. This ‘zombie drug’ has been approved by the country’s Food and Drug Administration…
Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease
LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for neurodegenerative diseases like Parkinson’s disease. – Co-research and co-development of novel microbiome…
Content Development Specialist at Elsevier
About Team Elsevier is the world’s leading provider of scientific, technical and medical information, tools and resources. A global company, Elsevier partners with scientists, researchers, healthcare providers, educators and decision-makers in academic institutions, governments and corporations. About the Content Development…
Cell mechanism that could help counter Cancer and Aging
Epigenetic memory is a key cell mechanism in processing of life that can controls the inheritance of functional characteristics of a normal cell into the new cell having newly acquired properties. In this activity cell remembers its originality while dividing…
Record-breaking copper catalyst converts CO2 into liquid fuels
Since the 1970s, scientists have known that copper has a special ability to transform carbon dioxide into valuable chemicals and fuels. But for many years, scientists have struggled to understand how this common metal works as an electrocatalyst, a mechanism…
